Supplier profile
Astrazeneca
Every public-sector award we hold for this supplier, across Australia, Belgium, Germany, Spain, Finland, France, the UK, Italy, Mexico, the Netherlands, New Zealand, Poland, Portugal and UK, from 16 Oct 2008 to 28 Jul 2026.
Awards won
598
all time
Attributed value
£304.0m + €22.6m + MXN 8.6bn + 2 more
205 shared, unvalued
Buyers
154
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Department of Health and Social Care | 3 | £304.0m |
| Department of Health and Social Care (DHSC) | 1 | £1 |
| Health | 49 | AUD 2.3m |
| NHS England | 38 | not attributable |
| The NHS Commissioning Board (operating under the name of NHS England) | 8 | not attributable |
| Centre hospitalier de Béziers | 7 | not attributable |
| CHU de Nantes | 6 | €583k |
| AP-HM | 5 | €1.8m |
| CHU de Reims | 5 | €49k |
| Kliniczny Szpital Wojewódzki nr 2 im. św. Jadwigi Królowej w Rzeszowie | 5 | not attributable |
What they win
Awards
Showing 426–450 of 598 awards we hold
- Adquisición de Medicamentos y Bienes Terapéuticos Para el Ejercicio Fiscal 2020 ↗£110k
- Medicinas y Productos Farmacéuticos Para el Incan. ↗£17.7m
- Medicinas y Productos Farmacéuticos ↗£2k
- Adquisicion Medicamentos Consolidada Aa-12-512-012000991-T-176-2023 ↗£9.9m
- Medicamentos y Bienes Terapéuticos Para el Primer Semestre del2022 Genérico (Bct) ↗£3.7m
- Adquisición de Medicamentos Consolidada 2023-2024 Para Medicamentos de Farmacia Gratuidad ↗£3.3m
- Meropenem 1Gr. /Merrem) ↗£2.6m
- Adquisición Consolidada de Productos Farmacéuticos Correspondiente Al Grupo Foca ↗£722.4m
- Medicamento, Compra Consolidada 2023-2024 ↗£1.4m
- Adquisición de Medicamentos de Patente (114 Claves) y Fuente Única (100 Claves) Para Los Ejercicios 2023-2024 ↗£3.8m
- Contratación Consolidada de Medicamentos y Bienes Terapéuticos 2020 ↗£44k
- Adquisicion Consolidada de 117 Claves de Medicamentos Patente Y/O Fuente Única ↗£4.6m
- Contrataciones Consolidadas de Medicamentos 2023 ↗£482k
- Medicinas y Productos Farmaceuticos ↗£949k
- Compra Consolidada de Medicamentos y Material de Curación Primer Bloque 2024 ↗£3.5m
- MEDICAL - PHARMACEUTICALS AND DRUGS ↗Health£57k
- Adquisición de Medicamentos de Patente (114 Claves) y Fuente Única (100 Claves) Para Los Ejercicios 2023-2024 ↗£1.2m
- MEDICAL - PHARMACEUTICALS AND DRUGS ↗Health£30k
- Adjudicación Directa Aa-012M7B998-E12-2022 Cons. (Ce-051Gyn007-E11-2022) ↗£1.8m
- MEDICAL - PHARMACEUTICALS AND DRUGS ↗Health£18k
- Consolidada de Medicamentos y Bienes Terapéuticos Para el Ejercicio Fiscal 2020 ↗£9.6m
- Adquisición de Medicamentos y Bienes Terapéuticos 2022 ↗£709k
- MEDICAL - PHARMACEUTICALS AND DRUGS ↗Health£44k
- Adquisición Consolidada de Medicamentos y Material de Curación (639 Claves) ↗£774k
- Adquisición Consolidada de Medicamentos y Bienes Terapéuticos Fase 2 (Bct) ↗£1.2m
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.